Immuno-Biological Laboratories Co., Ltd. Logo

Immuno-Biological Laboratories Co., Ltd.

Develops and supplies immunological research reagents and in-vitro diagnostic products.

4570 | T

Overview

Corporate Details

ISIN(s):
JP3921300004
LEI:
Country:
Japan
Address:
藤岡市中字東田1091番地1

Description

Immuno-Biological Laboratories (IBL) is a research and development-focused company that develops, manufactures, and supplies immunological research reagents and in-vitro diagnostic products for the global life sciences community. The company's core offerings include a comprehensive range of ELISA kits, antibodies, and cell culture-related products. IBL specializes in several key research areas, including aging, neurodegenerative disorders, kidney diseases, inflammatory diseases, and glucose/lipid metabolism. A notable proprietary technology is the LipoSEARCH® lipoprotein analyzing system, which uses patented GP-HPLC methods. The company also provides customized services to support specific research requirements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-14 01:01
四半期報告書-第42期第2四半期(2023/07/01-2023/09/30)
Japanese 190.6 KB
2023-08-14 02:08
確認書
Japanese 8.7 KB
2023-08-14 02:05
四半期報告書-第42期第1四半期(2023/04/01-2023/06/30)
Japanese 159.4 KB
2023-06-30 02:20
内部統制報告書-第41期(2022/04/01-2023/03/31)
Japanese 24.0 KB
2023-06-30 02:17
確認書
Japanese 8.7 KB
2023-06-30 02:14
有価証券報告書-第41期(2022/04/01-2023/03/31)
Japanese 1.2 MB
2023-02-13 01:02
確認書
Japanese 8.7 KB
2023-02-13 01:01
四半期報告書-第41期第3四半期(2022/10/01-2022/12/31)
Japanese 179.8 KB
2022-11-14 01:11
確認書
Japanese 8.8 KB
2022-11-14 01:03
四半期報告書-第41期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese 186.3 KB
2022-08-15 02:01
確認書
Japanese 8.7 KB
2022-08-15 02:00
四半期報告書-第41期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese 156.0 KB
2022-06-30 02:03
確認書
Japanese 8.8 KB
2022-06-30 02:03
内部統制報告書-第40期(令和3年4月1日-令和4年3月31日)
Japanese 24.2 KB
2022-06-30 02:02
有価証券報告書-第40期(令和3年4月1日-令和4年3月31日)
Japanese 1.1 MB

Automate Your Workflow. Get a real-time feed of all Immuno-Biological Laboratories Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Immuno-Biological Laboratories Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Immuno-Biological Laboratories Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.